Timeline Transparency Policy 0070

FLYER | Transparency Policy 0070

May 30, 2024

The EMA has progressively restarted the activities related to Policy 0070 for centrally authorised medicinal products for human use.

Have a look at this timeline that Asphalion experts have prepared for you to take into consideration the steps and timing regarding clinical data publication for new MAA. At the same time, you can also discover Asphalion’s expertise on the 0070 Policy linked to EMA milestones.

Watch the document here: TRANSPARENCY POLICY 0070

Reach out to us now to be ready for policy 0070 and learn how Asphalion can help you!

Contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting